HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alberto Calvi Selected Research
Alberto Calvi Research Topics
Disease
6
Multiple Sclerosis
11/2023 - 02/2013
2
Disease Progression
07/2017 - 12/2015
1
Cognitive Dysfunction
11/2023
1
Ganglion Cysts (Ganglion)
11/2023
1
Atrophy
11/2023
1
Gliosis
10/2023
1
Inflammation (Inflammations)
01/2022
1
Disease Susceptibility (Diathesis)
11/2018
1
Alzheimer Disease (Alzheimer's Disease)
01/2018
1
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
12/2017
1
Relapsing-Remitting Multiple Sclerosis
10/2017
1
Merkel Cell Carcinoma
10/2017
1
Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2015
1
Progressive Multifocal Leukoencephalopathy
01/2014
1
Edema (Dropsy)
01/2014
1
Intracranial Hypertension
01/2014
1
Immune Reconstitution Inflammatory Syndrome
01/2014
Drug/Important Bio-Agent (IBA)
3
Amyloid (Amyloid Fibrils)
IBA
01/2018 - 07/2017
3
Fingolimod Hydrochloride (FTY720)
FDA Link
10/2017 - 12/2015
2
Biomarkers (Surrogate Marker)
IBA
11/2018 - 07/2017
2
MicroRNAs (MicroRNA)
IBA
10/2016 - 02/2013
2
Steroids
IBA
12/2015 - 01/2014
2
Natalizumab (Tysabri)
FDA Link
12/2015 - 01/2014
1
Retinaldehyde (Retinal)
IBA
11/2023
1
N-acetylaspartate (N-acetyl aspartate)
IBA
10/2023
1
Choline (Choline Chloride)
IBA
10/2023
1
Creatine
IBA
10/2023
1
Fluoxetine (Prozac)
FDA Link
Generic
10/2023
1
Inositol (Myoinositol)
IBA
10/2023
1
Riluzole
FDA Link
Generic
10/2023
1
Iron
IBA
01/2022
1
Progranulins
IBA
01/2015
Therapy/Procedure
1
Therapeutics
01/2014
1
Critical Care (Surgical Intensive Care)
01/2014